Mode
Text Size
Log in / Sign up
Phase 4 N=58 Randomized Quadruple-blind Treatment

Study of the Insomnia in Patients With Low Back Pain

Primary Insomnia

Enrolled (actual)
58
Serious AEs
0.0%
Results posted
Jun 2013
Primary outcome: Primary: Mean Subjective Sleep Diary Derived Total Sleep Time (TST) — 316.96; 380.45; 403.47; 375.56 Minutes

Study Design & Population

Study type
Interventional
Phase
Phase 4
Interventions
Eszopiclone (Drug); Placebo (Drug)
Age
Adult · 21+ yrs
Sex
All
Sponsor
Duke University
Primary completion
Sep 2010

Outcome Measures

OutcomeResultp-value
PRIMARY
Mean Subjective Sleep Diary Derived Total Sleep Time (TST)
316.96; 380.45; 403.47; 375.56; 421.97; 382.11
SECONDARY
Visual Analog Scale Pain Ratings (VAS)
48.51; 53.79; 40.72; 51.99; 34.70; 51.25
SECONDARY
Mean Sleep Onset Latency (SOL)
38.28; 34.11; 22.36; 27.00; 17.50; 23.10
SECONDARY
Wake Time After Sleep Onset
91.51; 81.43; 49.34; 76.71; 37.07; 81.32
SECONDARY
Number of Awakenings
2.29; 2.08; 1.31; 1.98; 1.35; 2.13
SECONDARY
Sleep Quality Ratings
4.52; 4.44; 5.99; 4.90; 6.18; 5.33
SECONDARY
Insomnia Severity Index (ISI)
18.85; 20.26; 18.00; 16.78; 11.28; 12.85
SECONDARY
Patient Global Impression of Pain Ratings
4.02; 3.90; 3.54; 3.82; 3.30; 4.01
SECONDARY
Roland Morris Low Back Pain Inventory (RMLBPI)
12.27; 11.33; 9.97; 10.30; 9.10; 9.05
SECONDARY
Hamilton Depression Rating Scale (HAM-D-24)
6.45; 7.10; 6.38; 6.57; 4.54; 5.53
SECONDARY
Short Form 36 Health Survey Questionnaire (SF-36)
SECONDARY
State-Trait Anxiety Inventory (STAI)

Summary

The purpose of this study is to examine whether insomnia due to chronic low back pain can improve with use of eszopiclone.

Eligibility Criteria

Inclusion Criteria

  • • Diagnosis of insomnia based on DSM-IV criteria for insomnia due to a general medical condition (low-back pain);
  • The insomnia must not predate the onset of low-back pain by more than 1 month;
  • Usual nightly TST (Total Sleep Time) 30 minutes for the last month prior to screening;
  • ISI (Insomnia Severity Index) > 14 (at least moderate insomnia);
  • Age 21-64 years;
  • Greater than 40 on VAS (Visual Analog Scale) for pain (scale is 0-no pain to 100-worst imaginable pain);
  • Patient Global Impression of Pain of at least 3 (on a 1-5 scale, indicating at least moderate severity);
  • reported Back pain must be greater than reported leg pain, and there must be no signs of spinal nerve root compression;
  • presence of normal motor strength on exam;
  • duration of chronic low back pain of greater than three months;
  • low back pain location must be inferior to T12 and superior to the gluteal fold.

Exclusion Criteria

  • • Significant medical or neurological illness in excess of that which is directly responsible for the chronic low back pain;
  • the presence of an active and significant psychiatric disease with a substantive impact on sleep;
  • meeting DSM-IV criteria for an Axis I disorder within the last three months, or meeting criteria for substance abuse within the last 12 months;
  • current pregnancy; history of hypersensitivity, intolerance, or contraindication to Naproxen/Lansoprazole or Eszopiclone;
  • baseline creatinine of 2.0 or greater; patient taking other medications having significant renal effects (e.g. lithium, ACE inhibitor, angiotensin receptor antagonist, or thiazide/loop diuretics);
  • patients taking other anticoagulants; patients having an allergy to aspirin; history of diagnosed gastric or duodenal ulcer;
  • history of bleeding or clotting diathesis; lifetime history of myocardial infarction or cerebrovascular accident;
  • Elevated PT/PTT/INR (Prothrombin Time, Partial Thromboplastin Time, International Normalized Ratio)at screening;
  • Abnormal kidney function detected in screening labs;
  • history of back related surgery within the past 3 months; history of corticosteroid use in the past 30 days;
  • presence of currently pending litigation or worker's compensation claim related to the chronic low back pain;
  • inability to follow study procedures or complete the study; or the use of any medications that could affect sleep within 5 half-lives of screening;
  • history of back surgery within the past 2 years with the exception of a discectomy;
  • pregnant or lactating females;
  • women of child-bearing potential who will not agree to use approved means of birth control during the trial;
  • history of any surgery within the past one month; history of any major physical trauma within the last 6 months;
  • history of corticosteroid use within the last 90 days; diagnosis of rheumatoid or psoriatic arthritis;
  • history of fibromyalgia;
  • presence of spondyloarthropathy;
  • presence of sciatica;
  • spinal stenosis;
  • presence of any vertebral fractures, spondylolisthesis; or radicular back pain.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00365976). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search